Purdue lands $100M for cancer drug Pluvicto royalties
Purdue University plans to use the funding to further support research at the university.
Purdue University plans to use the funding to further support research at the university.
Fishers-based INCOG Biopharma Services Inc., one of the newest players in the $132 billion contract drug manufacturing industry, acts as a behind-the-scenes player for companies that need to get sterile injectable medicines to market in a hurry.
The court extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s Food and Drug Administration approval continues.
The expansion will bring Eli Lilly and Co.’s total investment in the project to $3.7 billion, the most the company has ever spent on a single manufacturing site.
The Indiana House bill is key to providing women quicker access to contraceptives, bill sponsor Republican Sen. Sue Glick said Tuesday, especially in areas where they struggle to receive primary care.
A federal judge in Texas blocked U.S. government approval of a key abortion medication Friday, siding with abortion foes in an unprecedented lawsuit and potentially upending nationwide access to the pill widely used to terminate pregnancies.
A pharmacist convicted of producing and distributing adulterated drugs was not entitled to attorney fees in his case against the Indiana Board of Pharmacy, which was entitled to immunity, the Court of Appeals of Indiana has ruled.
The donation comes from the former CEO of Santa Barbara Specialty Pharmacy, which services California and five nearby states.
The Lebanon Plan Commission voted unanimously Monday to approve Eli Lilly and Co.’s development plan for its two manufacturing facilities in Boone County.
Illuccix was first approved by the FDA in December 2021. The imaging agent is designed to target and “light up” cancerous cells, making it easier for oncologists to determine through a PET scan if the cells have spread to areas outside the prostate.
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.
Eli Lilly said the study concludes its clinical development of solanezumab, apparently shutting the door on one of the most closely watched experimental drugs over the past decade.
The decision comes after Attorney General Todd Rokita and 19 other attorneys general threatened legal action if the pharmacy company sells the pills by mail.
The Weinberg Center for Corporate Governance at the University of Delaware, a leading voice for responsible corporate leadership, has generally supported the elimination of staggered terms, saying they can lead to entrenched boards and management that fails to perform.
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
The Indianapolis-based drugmaker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.
The potential move represents the latest government effort to increase use of a medication that has been a key tool in the battle against the U.S. overdose epidemic that kills more than 100,000 people annually.
Jaypirca was approved to treat mantle cell lymphoma, or MCL. a rare blood cancer that starts in white blood cells in the lymph nodes for which there is no cure, according to Lilly. The disease affects about 1 in 200,000 people worldwide each year.
Donanemab’s ability to rapidly remove amyloid beta from patients’ brains prevented the required number of patients from receiving the drug for a full 12 months, Lilly said, resulting in the FDA rejection.
The Indianapolis company, located in the former St. Bernadette Catholic Church on the near-east side, plans to make the hires by the end of 2025.